Rob Perry is an experienced professional in the field of quality assurance and management, with a strong focus on cell and gene therapy. Currently serving as the Head of Quality for Cell & Gene Therapy at Roche, Rob has previously held the position of Quality Site Head for Individualized Therapies at Genentech, and Quality Site Head at Roche. Prior experience includes serving as the Director of Quality Assurance at Novartis, further establishing a robust background in quality management within the pharmaceutical and biotechnological sectors.
This person is not in the org chart
This person is not in any teams
This person is not in any offices